CONGENITAL ANOMALIES

Scope & Guideline

Advancing knowledge on congenital disorders.

Introduction

Immerse yourself in the scholarly insights of CONGENITAL ANOMALIES with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0914-3505
PublisherWILEY
Support Open AccessNo
Country-
TypeJournal
Convergefrom 1973 to 2019, 2021 (coverage discontinued in Scopus)
AbbreviationCONGENIT ANOM / Congenit. Anom.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "CONGENITAL ANOMALIES" focuses on a wide range of research pertaining to congenital disorders, emphasizing their etiology, diagnosis, management, and prevention. It serves as a platform for studies that explore genetic, environmental, and therapeutic aspects of congenital anomalies, contributing significantly to the understanding and treatment of these conditions.
  1. Genetic and Molecular Studies:
    Research exploring the genetic underpinnings of congenital anomalies, including novel gene variants and their associations with specific syndromes.
  2. Prenatal Diagnosis and Management:
    Focus on advancements in prenatal screening techniques and management strategies for pregnancies complicated by congenital anomalies.
  3. Epidemiological Studies:
    Investigations into the prevalence, risk factors, and demographic trends related to congenital anomalies across different populations.
  4. Clinical Outcomes and Case Reports:
    Detailed case studies highlighting clinical presentations, treatment outcomes, and long-term follow-up of patients with congenital disorders.
  5. Therapeutic Interventions:
    Studies evaluating the effectiveness of various treatment modalities, including surgical and pharmacological interventions for congenital anomalies.
The journal has seen a rise in interest in certain emerging themes, reflecting ongoing advances in medical science and a growing awareness of congenital anomalies' complexities.
  1. Pharmacovigilance and Drug Safety:
    An increase in studies examining the safety of medications during pregnancy and their implications for congenital anomalies indicates a growing concern for maternal-fetal medicine.
  2. Integrated Approaches to Diagnosis:
    Emerging themes include the use of advanced imaging techniques and genetic testing for early diagnosis of congenital anomalies, showcasing a trend towards more comprehensive diagnostic strategies.
  3. Public Health and Awareness:
    Research focused on public awareness and education regarding congenital anomalies is gaining traction, emphasizing the importance of community engagement in prevention and management.
  4. Maternal Health and Lifestyle Factors:
    There is a rising trend in studies exploring the impact of maternal health, lifestyle choices, and environmental exposures on the risk of congenital anomalies.

Declining or Waning

While "CONGENITAL ANOMALIES" continues to explore a broad array of topics, certain themes have shown a decline in publication frequency. This may reflect shifts in research funding, interest, or advancements in related fields.
  1. Environmental Teratology:
    Research focusing on environmental factors contributing to congenital anomalies has decreased, possibly due to a shift towards genetic and molecular studies.
  2. Historical Case Studies:
    Papers documenting historical cases of congenital anomalies are becoming less frequent, as the focus shifts towards contemporary clinical practices and outcomes.
  3. Surgical Techniques and Innovations:
    There is a noticeable decline in the publication of studies solely focused on surgical techniques for congenital anomalies, as the journal emphasizes broader clinical outcomes.

Similar Journals

Translational Pediatrics

Bridging Research and Care for Healthier Futures.
Publisher: AME PUBLISHING COMPANYISSN: 2224-4336Frequency: 12 issues/year

Translational Pediatrics is a leading journal in the field of Pediatrics, specializing in bridging the gap between laboratory research and clinical practice. Published by AME Publishing Company in Hong Kong, this journal aims to promote the translation of scientific discoveries into innovative interventions for child health. With its ISSN 2224-4336 and E-ISSN 2224-4344, the journal is accessible to a global audience, enhancing knowledge sharing among researchers, clinicians, and educators. Recognized in 2023 as a Q2 category journal in Pediatrics, Perinatology, and Child Health, it ranks 72nd out of 330 according to Scopus, placing it in the top 22% of its category. With an impactful Convergence of research from 2015 to 2024, Translational Pediatrics is dedicated to providing an essential platform for high-quality studies that advance pediatric care and foster best practices in child health.

AJP Reports

Connecting the dots in maternal and child health innovation.
Publisher: THIEME MEDICAL PUBL INCISSN: 2157-6998Frequency: 2 issues/year

AJP Reports, published by THIEME MEDICAL PUBL INC, is a distinguished open-access journal that has been making valuable contributions to the fields of Obstetrics and Gynecology and Pediatrics, Perinatology, and Child Health since its inception in 2011. With its ISSN 2157-6998 and E-ISSN 2157-7005, the journal serves as a crucial platform for the dissemination of groundbreaking research and clinical practice advancements. According to the 2023 categorization, it is ranked in the third quartile for Obstetrics and Gynecology and the second quartile for Pediatrics, Perinatology, and Child Health, reflecting its importance in these fields. The journal is committed to accessibility, ensuring that all published studies can reach a broad audience of researchers, practitioners, and students, ultimately fostering collaboration and innovation. As it converges its database from 2014 to 2024, AJP Reports continues to play a pivotal role in enhancing the understanding and management of maternal and child health issues, making it an essential resource for those at the forefront of these vital medical specialties.

Congenital Heart Disease

Navigating the future of congenital heart disease management.
Publisher: TECH SCIENCE PRESSISSN: 1747-079XFrequency: 6 issues/year

Congenital Heart Disease, published by TECH SCIENCE PRESS, is a pivotal academic journal focusing on the complexities of congenital heart conditions. With an ISSN of 1747-079X and an E-ISSN of 1747-0803, this journal serves as a crucial platform for researchers and healthcare professionals engaged in cardiology, pediatrics, and related fields. Established in 2006 and continuing through to 2024, it aims to disseminate insightful research findings and reviews that advance the understanding of congenital heart diseases and their management. The journal currently holds a Q4 classification in cardiology and cardiovascular medicine, with rankings in various medical categories highlighting its dedication to emerging research. Although it does not offer open access, its contributions are vital for professionals seeking to explore innovative strategies and collaborative solutions in congenital heart disease management. As it continues to navigate the evolving landscape of pediatric cardiac health, Congenital Heart Disease is committed to fostering a community of knowledge that impacts both clinical practices and academic inquiry.

Molecular and Clinical Oncology

Advancing cancer research for a healthier tomorrow.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

Clinical Medicine Insights-Pediatrics

Fostering Collaboration for Next-Gen Pediatric Solutions
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5565Frequency: 1 issue/year

Clinical Medicine Insights-Pediatrics, published by SAGE Publications Ltd, stands at the forefront of pediatric healthcare research, providing an essential platform for the dissemination of innovative findings and clinical advances. As an Open Access journal since 2010, it ensures that high-quality research is accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, healthcare professionals, and educators. Although the journal's H-index and Scopus Ranks are not specified, it remains committed to enhancing understanding and treatment of pediatric conditions by publishing rigorous studies, reviews, and case reports. With a focus on evidence-based practices and clinical insights, Clinical Medicine Insights-Pediatrics plays a pivotal role in addressing the unique health challenges faced by children today, making it an indispensable resource for anyone dedicated to advancing pediatric health.

NATURE MEDICINE

Exploring Breakthroughs for Tomorrow's Healthcare
Publisher: NATURE PORTFOLIOISSN: 1078-8956Frequency: 12 issues/year

NATURE MEDICINE, published by NATURE PORTFOLIO, is a premier journal in the fields of medicine and biochemistry, recognized for its rigorous peer-review process and high-impact research contributions. With an impressive Scopus ranking placing it in the top percentile—#3 out of 636 in General Medicine and #2 out of 221 in General Biochemistry, Genetics, and Molecular Biology—it embodies excellence and innovation in biomedical science. The journal has been a vital source of cutting-edge discoveries since its inception in 1995, and it encompasses a wide range of topics including clinical research, translational medicine, and advances in genetic technologies. The journal’s impact factor reflects its significance, making it an essential resource for researchers, professionals, and students aiming to stay at the forefront of medical science. Though the journal follows a subscription model, it remains crucial for disseminating pivotal research findings that shape the future of healthcare and therapeutic strategies worldwide.

Birth Defects Research

Empowering the scientific community through open access.
Publisher: WILEYISSN: 2472-1727Frequency: 20 issues/year

Birth Defects Research is a premier open-access academic journal published by WILEY, dedicated to advancing the field of developmental biology and embryology, with an emphasis on understanding the mechanisms and factors influencing congenital anomalies. Since its establishment, the journal serves as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and insights in areas including pediatrics, toxicology, and health science. With an impact factor reflecting its commitment to quality, it is positioned in the Q2 and Q3 quartiles across several categories for 2023, demonstrating its relevance and influence within the scientific community. Researchers will find it particularly valuable for disseminating findings and encouraging interdisciplinary collaboration in combatting birth defects and improving child health outcomes. Accessible from the United Kingdom, the journal fosters the free exchange of information, reinforcing its goal to support the global health landscape through knowledge and innovation.

Molecular Cytogenetics

Empowering Researchers through Open Access Knowledge.
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Cytogenetics is a prestigious open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. Since its inception in 2008, this journal has facilitated prominent research and developments in the cytogenetics domain, featuring innovative studies and reviews that explore the intricate relationship between cellular structures, genetic makeup, and various biological processes. With a robust impact factor and a commendable positioning within Q3 and Q4 categories across multiple relevant disciplines, it provides a vital platform for researchers to disseminate their findings to a global audience. The journal's open-access model ensures that cutting-edge research is readily available to students, professionals, and scholars, promoting free knowledge exchange. Situated in the vibrant landscape of the United Kingdom, Molecular Cytogenetics continues to contribute significantly to scientific progress, solidifying its role as an essential resource for those engaged in the exploration of genetic and cytogenetic inquiry.

OPHTHALMIC GENETICS

Connecting Genetic Insights to Clinical Eye Care
Publisher: TAYLOR & FRANCIS INCISSN: 1381-6810Frequency: 4 issues/year

OPHTHALMIC GENETICS is a distinguished journal published by TAYLOR & FRANCIS INC, specializing in the intersection of genetics and ophthalmology. Established in 1981, the journal has become a vital resource for researchers, clinicians, and students interested in the genetic aspects of eye diseases and disorders. Despite not being an Open Access journal, it maintains a commendable impact within the academic community, as reflected by its Q3 ranking in clinical genetics and Q2 rankings in both ophthalmology and pediatrics in 2023. With a robust focus on clinical applications, OPHTHALMIC GENETICS aims to provide a platform for innovative research and insights that drive advancements in patient care and understanding of genetic conditions affecting vision. The journal's international readership is supported by its timely publication of articles that bridge the gap between genetic research and practical ophthalmological applications.

ANATOMICAL SCIENCE INTERNATIONAL

Unveiling Innovations in Anatomical Science
Publisher: SPRINGERISSN: 1447-6959Frequency: 4 issues/year

ANATOMICAL SCIENCE INTERNATIONAL is a distinguished peer-reviewed journal published by SPRINGER, focusing on the field of anatomy and its applications within the broader spectrum of medical science. With an ISSN of 1447-6959 and an E-ISSN of 1447-073X, this journal provides a robust platform for the dissemination of innovative research and findings from around the globe, featuring studies that span from basic anatomy to advanced clinical applications. As of 2023, it holds a respectable Q2 rank in Anatomy and a Q3 rank in the miscellaneous category of Medicine, reflecting its growing influence and contribution to the field, with Scopus rankings placing it in the 59th percentile of Medicine - Anatomy journals. Although ANATOMICAL SCIENCE INTERNATIONAL is not an Open Access journal, it remains indispensable for researchers, professionals, and students who seek to stay at the forefront of anatomical science research. The journal's ongoing commitment to excellence is evident through its continuous publication, spanning from 2002 and projected through 2024, making it a vital resource for those aiming to advance their knowledge and practice in anatomy.